Abstract
Systems biology represents an integrative research strategy that studies the interactions between DNA, mRNA, protein, and metabolite level in an organism, thereby including the interactions with the physical environment and other organisms. The application of metabonomics, or the quantitative study of metabolites in biological systems, in systems biology is currently an emerging area of research, which can contribute to the discovery of (disease) signatures, drug targeting and design, and the further elucidation of basic and more complex biochemical principles. This chapter covers the contribution of metabonomics in advancing our understanding in systems biology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Westerhoff HV, Palsson BO (2004) The evolution of molecular biology into systems biology. Nat Biotechnol 22:1249–1252
Petranovic D, Tyo K, Vemuri GN et al (2010) Prospects of yeast systems biology for human health: integrating lipid, protein and energy metabolism. FEMS Yeast Res 10:1046–1059
Snoep JL, Bruggeman F, Olivier BG et al (2006) Towards building the silicon cell: a modular approach. BioSystems 83:207–216
Hood L, Rowen L, Galas DJ et al (2008) Systems biology at the Institute for Systems Biology. Brief Funct Genomic Proteomic 7:239–248
Lazebnik Y (2002) Can a biologist fix a radio?—Or, what I learned while studying apoptosis. Cancer Cell 2:179–182
Hyotylainen T, Oresic M (2014) Systems biology strategies to study lipidomes in health and disease. Prog Lipid Res 55:43–60. doi:10.1016/j.plipres.2014.06.001
Fiehn O (2002) Metabolomics: the link between genotypes and phenotypes. Plant Mol Biol 48:155–171
Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189
Ellis DI, Dunn WB, Griffin JL et al (2007) Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics 8:1243–1266
De Preter V, Verbeke K (2013) Metabolomics as a diagnostic tool in gastroenterology. World J Gastrointest Pharmacol Ther 4:97–107
Lu W, Bennett BD, Rabinowitz JD (2008) Analytical strategies for LC-MS-based targeted metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci 871:236–242
Pasikanti KK, Ho PC, Chan EC (2008) Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. J Chromatogr B Analyt Technol Biomed Life Sci 871:202–211
Kitano H (2002) Systems biology: a brief overview. Science 295:1662–1664
Holmes E, Wilson ID, Nicholson JK (2008) Metabolic phenotyping in health and disease. Cell 134:714–717
Heather LC, Wang X, West JA et al (2013) A practical guide to metabolomic profiling as a discovery tool for human heart disease. J Mol Cell Cardiol 55:2–11
Assfalg M, Bertini I, Colangiuli D et al (2008) Evidence of different metabolic phenotypes in humans. Proc Natl Acad Sci U S A 105:1420–1424
Nicholson JK, Lindon JC (2008) Systems biology: metabonomics. Nature 455:1054–1056
Jenkins M, Flynn A, Smart T et al (2011) PSI Biomarker Special Interest Group. A statistician’s perspective on biomarkers in drug development. Pharm Stat 10:494–507
Xia J, Broadhurst DI, Wilson M et al (2013) Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 9:280–299
Nielsen J, Oliver S (2005) The next wave in metabolome analysis. Trends Biotechnol 23:544–546
Mardinoglu A, Nielsen J (2012) Systems medicine and metabolic modelling. J Intern Med 271:142–154
Alexandersson E, Jacobson D, Vivier MA et al (2014) Field-omics-understanding large-scale molecular data from field crops. Front Plant Sci 5:286
Jewett MC, Hofmann G, Nielsen J (2006) Fungal metabolite analysis in genomics and phenomics. Curr Opin Biotechnol 17:191–197
Sekirov I, Russell SL, Antunes LC et al (2010) Gut microbiota in health and disease. Physiol Rev 90:859–904
Cho I, Blaser MJ (2012) The human microbiome: at the interface of health and disease. Nat Rev Genet 13:260–270
van Baarlen P, Kleerebezem M, Wells JM (2013) Omics approaches to study host-microbiota interactions. Curr Opin Microbiol 16:270–277
Joossens M, Huys G, Cnockaert M et al (2011) Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut 60:631–637
Krogius-Kurikka L, Lyra A, Malinen E et al (2009) Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 9:95
De Preter V, Machiels K, Joossens M et al (2014) Fecal metabolite profiling identifies medium chain fatty acids as discriminating compounds for inflammatory bowel disease. Gut. doi:10.1136/gutjnl-2013-306423
Bjerrum JT, Rantalainen M, Wang Y et al (2014) Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitis. Metabolomics 10:280–290
Bjerrum JT, Wang Y, Hao F et al (2014) Metabonomics of human fecal extracts characterize ulcerative colitis. Crohn’s disease and healthy individuals. Metabolomics. doi:10.1007/s11306-014-0677-3
Berndt U, Bartsch S, Philipsen L et al (2007) Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn’s disease and ulcerative colitis. J Immunol 179:295–304
Olsen J, Gerds TA, Seidelin JB et al (2009) Diagnosis of ulcerative colitis before onset of inflammation by multivariate modeling of genome-wide gene expression data. Inflamm Bowel Dis 15:1032–1038
Arijs I, Quintens R, Van Lommel L et al (2010) Predictive value of epithelial gene expression profiles for response to infliximab in Crohn’s disease. Inflamm Bowel Dis 16:2090–2098
Lamendella R, Verberkmoes N, Jansson JK (2012) ‘Omics’ of the mammalian gut—new insights into function. Curr Opin Biotechnol 23:491–500
Yau Y, Leong RW, Zeng M et al (2013) Proteomics and metabolomics in inflammatory bowel disease. J Gastroenterol Hepatol 28:1076–1086
Av G, Flatberg A, Østvik AE et al (2013) Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn’s disease and ulcerative colitis. PLoS One 8:e56818
Barallobre-Barreiro J, Chung YL, Mayr M (2013) Proteomics and metabolomics for mechanistic insights and biomarker discovery in cardiovascular disease. Rev Esp Cardiol (Engl Ed) 66:657–661
Mayr M, Yusuf S, Weir G et al (2008) Combined metabolomic and proteomic analysis of human atrial fibrillation. J Am Coll Cardiol 51:585–594
Gieger C, Geistlinger L, Altmaier E et al (2008) Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 4:e1000282
Kim H-Y, Kim H-R, Lee S-H (2014) Advances in systems biology approaches for autoimmune diseases. Immune Netw 14:73–80
Blumberg RS, Dittel B, Hafler D et al (2012) Unraveling the autoimmune translational research process layer by layer. Nat Med 18:35–41
Ghosh D, Poisson LM (2009) “Omics” data and levels of evidence for biomarker discovery. Genomics 93:13–16
Wu T, Xie C, Han J et al (2012) Metabolic disturbances associated with systemic lupus erythematosus. PLoS One 7:e37210
Ouyang X, Dai Y, Wen JL et al (2011) (1)H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus. Lupus 20:1411–1420
Balderas C, Rupérez FJ, Ibañez E et al (2013) Plasma and urine metabolic fingerprinting of type 1 diabetic children. Electrophoresis 34:2882–2890
Dutta T, Chai HS, Ward LE et al (2012) Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes. Diabetes 61:1004–1016
Scott DL, Wolfe F, Huizinga TJW (2010) Rheumatoid arthritis. Lancet 376:1094–1108
Young SP, Kapoor SR, Viant MR et al (2013) The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum 65:2015–2023
Priori R, Scrivo R, Brandt J et al (2013) Metabolomics in rheumatic diseases: the potential of an emerging methodology for improved patient diagnosis, prognosis, and treatment efficacy. Autoimmun Rev 12:1022–1030
Kitteringham NR, Jenkins RE, Lane CS et al (2009) Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci 877:1229–1239
Wenk MR (2005) The emerging field of lipidomics. Nat Rev Drug Discov 4:594–610
Lam SM, Shui G (2013) Lipidomics as a principal tool for advancing biomedical research. J Gen Genom 40:375–390
Hong MG, Karlsson R, Magnusson PK et al (2013) A genome-wide assessment of variability in human serum metabolism. Hum Mutat 34:515–524
Mikami T, Aoki M, Kimura T (2012) The application of mass spectrometry to proteomics and metabolomics in biomarker discovery and drug development. Curr Mol Pharmacol 5:301–316
Wishart DS (2008) Applications of metabolomics in drug discovery and development. Drugs R D 9:307–322
van der Greef J, McBurney RN (2005) Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nat Rev Drug Discov 4:961–967
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
De Preter, V. (2015). Metabonomics and Systems Biology. In: Bjerrum, J. (eds) Metabonomics. Methods in Molecular Biology, vol 1277. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2377-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2377-9_17
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2376-2
Online ISBN: 978-1-4939-2377-9
eBook Packages: Springer Protocols